Hudson Bay Capital Management LP Sutro Biopharma, Inc. Transaction History

Hudson Bay Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.92 - $5.33 $177,422 - $323,856	60,761 New	60,761 $178,000
Q1 2022 May 16, 2022	SELL	$7.78 - $15.31 $789,670 - $1.55 Million	-101,500 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$14.25 - $23.53 $733,875 - $1.21 Million	51,500 Added 103.0%	101,500 $1.51 Million
Q3 2021 Nov 15, 2021	BUY	$16.88 - $22.38 $422,000 - $559,500	25,000 Added 100.0%	50,000 $945,000
Q2 2021 Aug 16, 2021	BUY	$18.03 - $23.82 $450,750 - $595,500	25,000 New	25,000 $465,000

136

62.4M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $131M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Hudson Bay Capital Management LP with notifications on news.